High SPRR1A expression is associated with poor survival in patients with colon cancer

Deng,Yu; Zheng,Xin; Zhang,Yiyi; Xu,Meifang; Ye,Chengwei; Lin,Mengxin; Pan,Jie; Xu,Zongbin; Lu,Xingrong; Chi,Pan

doi:10.3892/ol.2020.11453

May-2020 Volume 19 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2020 Volume 19 Issue 5

Full Size Image

Article Open Access

High SPRR1A expression is associated with poor survival in patients with colon cancer

Authors:
- Yu Deng
- Xin Zheng
- Yiyi Zhang
- Meifang Xu
- Chengwei Ye
- Mengxin Lin
- Jie Pan
- Zongbin Xu
- Xingrong Lu
- Pan Chi
View Affiliations / Copyright

Affiliations: Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China, Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China, Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China, Department of Emergency Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China

Copyright: © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 3417-3424
|
Published online on: March 10, 2020

https://doi.org/10.3892/ol.2020.11453
Expand metrics +

Abstract

High expression of small proline‑rich protein 1A (SPRR1A) has been shown to be associated with tumor prognosis; however, the association between SPRR1A expression and colon cancer prognosis remains unclear. The present study sought to evaluate the association between SPRR1A expression and the clinicopathological characteristics of colon cancer, and to examine its potential prognostic value. A total of 114 patients with colon cancer were included. SPRR1A expression was evaluated by immunohistochemical staining, and the association between SPRR1A expression and clinicopathological parameters was analyzed. The prognostic value of SPRR1A was analyzed by Cox regression analysis, the Oncomine database and the R2 platform. SPRR1A expression was significantly increased in cancerous tissues compared with that in adjacent non‑cancerous tissues. SPPRR1A expression was significantly associated with lymph node invasion. High SPRR1A expression was significantly associated with worse overall and disease‑free survival rate. Cox regression analysis revealed that T stage, pathological N stage and high SPRR1A expression remained independent predictors for overall survival rate. The Oncomine database analysis demonstrated that SPRR1A mRNA expression levels were significantly increased in colorectal cancer tissues compared with those in adjacent non‑cancerous tissues, and high SPRR1A expression was associated with a significantly worse event‑ and relapse‑free survival time in the R2 platform. The data indicate that SPRR1A may serve as a potential biomarker for the prognosis of colon cancer.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Mahar AL, Compton C, Halabi S, Hess KR, Weiser MR and Groome PA: Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol. 116:969–982. 2017. View Article : Google Scholar : PubMed/NCBI
3	Bardhan K and Liu K: Epigenetics and colorectal cancer pathogenesis. Cancers (Basel). 5:676–713. 2013. View Article : Google Scholar : PubMed/NCBI
4	Mouradov D, Domingo E, Gibbs P, Jorissen RN, Li S, Soo P, Lipton L, Desai J, Danielsen HE, Oukrif D, et al: Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations. Am J Gastroenterol. 108:1785–1793. 2013. View Article : Google Scholar : PubMed/NCBI
5	Das V, Kalita J and Pal M: Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges. Biomed Pharmacother. 87:8–19. 2017. View Article : Google Scholar : PubMed/NCBI
6	Fujimoto W, Nakanishi G, Arata J and Jetten AM: Differential expression of human cornifin alpha and beta in squamous differentiating epithelial tissues and several skin lesions. J Invest Dermatol. 108:200–204. 1997. View Article : Google Scholar : PubMed/NCBI
7	Gibbs S, Fijneman R, Wiegant J, van Kessel AG, van De Putte P and Backendorf C: Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics. 16:630–637. 1993. View Article : Google Scholar : PubMed/NCBI
8	De Heller-Milev M, Huber M, Panizzon R and Hohl D: Expression of small proline rich proteins in neoplastic and inflammatory skin diseases. Br J Dermatol. 143:733–740. 2000. View Article : Google Scholar : PubMed/NCBI
9	Zhang H, Gao J, Zhao Z, Li M and Liu C: Clinical implications of SPRR1A expression in diffuse large B-cell lymphomas: A prospective, observational study. BMC Cancer. 14:3332014. View Article : Google Scholar : PubMed/NCBI
10	Pavón MA, Arroyo-Solera I, León X, Téllez-Gabriel M, Virós D, Gallardo A, Céspedes MV, Casanova I, Lopez-Pousa A, Barnadas A, et al: The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes. Head Neck. 41:1830–1845. 2019. View Article : Google Scholar : PubMed/NCBI
11	Chen G, Li G, Luo M, Wei X, Wang D, Zhang H, Zhao X, Chen B and Liu C: Clinical significance of SPRR1A expression in progesterone receptor-positive breast cancer. Tumour Biol. 36:2601–2605. 2015. View Article : Google Scholar : PubMed/NCBI
12	Leclerc D, Lévesque N, Cao Y, Deng L, Wu Q, Powell J, Sapienza C and Rozen R: Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients. Cancer Prev Res (Phila). 6:1171–1181. 2013. View Article : Google Scholar : PubMed/NCBI
13	Hammoud SS, Cairns BR and Jones DA: Epigenetic regulation of colon cancer and intestinal stem cells. Curr Opin Cell Biol. 25:177–183. 2013. View Article : Google Scholar : PubMed/NCBI
14	Edge S: American Joint Committee on Cancer: AJCC cancer staging manual. 7th. New York: Springer; 2010
15	Qiu J, Liu P, Shi C and Han B: Low-grade myofibroblastic sarcomas of the maxilla. Oncol Lett. 9:619–625. 2015. View Article : Google Scholar : PubMed/NCBI
16	Zhang Y, Xu Z, Sun Y, Chi P and Lu X: Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell. Onco Targets Ther. 11:809–821. 2018. View Article : Google Scholar : PubMed/NCBI
17	Koster J, Molenaar J and Versteeg R: Abstract B1-05: R2: Accessible web-based genomics analysis and visualization platform for biomedical researchers. Cancer Res. 757:B1–B5. 2015.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

High SPRR1A expression is associated with poor survival in patients with colon cancer

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles